Amylyx Pharmaceuticals Inc (AMLX)
NASDAQ:AMLX
US Market
Holding AMLX?
Track your performance easily

Amylyx Pharmaceuticals Inc (AMLX) Ownership - Who Owns Amylyx Pharmaceuticals Inc?

510 Followers

Amylyx Pharmaceuticals Inc (AMLX) Ownership Overview

16.97%8.90%1.70%6.82%65.61%
16.97% Insiders
1.70% Other Institutional Investors
6.82% ETFs
65.61% Public Companies and
Individual Investors
The ownership structure of Amylyx Pharmaceuticals Inc (AMLX) stock is a mix of institutional, retail, and individual investors. Approximately 17.41% of the company’s stock is owned by Institutional Investors, 16.97% is owned by Insiders, and 65.61% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 02, 2024
Justin B. Klee
Co Ceo,director
xxxxxxxxxxxxx
$59299
Oct 02, 2024
Joshua B Cohen
Co Ceo,director
xxxxxxxxxxxxx
$59299
Oct 02, 2024
xxxxxxxxxxxxx
$36500
Oct 02, 2024
xxxxxxxxxxxxx
$27782

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$611547

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,415,785Institution5.02%22,885,760
3,220,569Insider4.73%21,577,812
3,202,381Insider4.70%21,455,953
3,184,259Insider4.68%21,334,535
2,962,555Institution4.35%19,849,119
2,563,205Institution3.76%17,173,474
1,150,221Institution1.69%7,706,481
936,967Institution1.38%6,277,679
858,571Insider1.26%5,752,426
846,240Institution1.24%5,669,808

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,415,785Institution5.02%22,885,760
384,510Institution0.56%2,576,217
348,375Institution0.51%2,334,113
342,895Institution0.50%2,297,397
300,790Institution0.44%2,015,293
254,005Institution0.37%1,701,834
157,412Institution0.23%1,054,660
147,666Institution0.22%989,362
130,000Institution0.19%871,000
114,800Institution0.17%769,160

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,811,143Institution2.66%5,868,103
387,802Institution0.57%2,345,750
292,086Institution0.43%1,956,976
600,395Institution0.88%1,945,280
268,626Institution0.39%1,799,794
246,669Institution0.36%1,613,215
183,055Institution0.27%1,197,180
183,055Institution0.27%1,197,180
141,924Institution0.21%950,891
151,667Institution0.22%491,401

FAQ

Who Owns Amylyx Pharmaceuticals Inc (AMLX)?
According to the latest TipRanks data, approximately 1.70% of the company's stock is held by institutional investors, 16.97% is held by insiders, and 65.61% is held by retail investors.
    What percentage of Amylyx Pharmaceuticals Inc (AMLX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.70% of Amylyx Pharmaceuticals Inc (AMLX) stock is held by institutional investors.
      What percentage of Amylyx Pharmaceuticals Inc (AMLX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 65.61% of Amylyx Pharmaceuticals Inc (AMLX) stock is held by retail investors.
        Who owns the most shares of Amylyx Pharmaceuticals Inc (AMLX)?
        VANGUARD INDEX FUNDS owns the most shares of Amylyx Pharmaceuticals Inc (AMLX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis